HEADER DNA 20-MAR-00 1EN1 TITLE STRUCTURE OF THE HIV-1 MINUS STRAND PRIMER BINDING SITE CAVEAT 1EN1 INCORRECT CHIRALITY OF C4' BACKBONE CARBONS COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA (5'- COMPND 3 D(P*GP*TP*CP*CP*CP*TP*GP*TP*TP*CP*GP*GP*GP*CP*GP*CP*CP*A)-3'); COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS HAIRPIN, PENTALOOP, BULGE, DNA EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR P.E.JOHNSON,R.B.TURNER,Z.R.WU,J.G.LEVIN,M.F.SUMMERS REVDAT 4 28-DEC-11 1EN1 1 CAVEAT VERSN REVDAT 3 24-FEB-09 1EN1 1 VERSN REVDAT 2 08-FEB-05 1EN1 1 JRNL CAVEAT REMARK REVDAT 1 04-APR-00 1EN1 0 JRNL AUTH P.E.JOHNSON,R.B.TURNER,Z.R.WU,L.HAIRSTON,J.GUO,J.G.LEVIN, JRNL AUTH 2 M.F.SUMMERS JRNL TITL A MECHANISM FOR PLUS-STRAND TRANSFER ENHANCEMENT BY THE JRNL TITL 2 HIV-1 NUCLEOCAPSID PROTEIN DURING REVERSE TRANSCRIPTION JRNL REF BIOCHEMISTRY V. 39 9084 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 10924101 JRNL DOI 10.1021/BI000841I REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA 1.5 REMARK 3 AUTHORS : GUNTERT REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ONLY RESTRAINTS FOR THE STRUCTURED REMARK 3 PORTION OF THE OLIGONUCLEOTIDE (NUCLEOTIDES 1-14) WERE USED REMARK 3 DURING REFINEMENT. REMARK 4 REMARK 4 1EN1 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAR-00. REMARK 100 THE RCSB ID CODE IS RCSB010737. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 297; 278 REMARK 210 PH : NULL; NULL REMARK 210 IONIC STRENGTH : NULL; NULL REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 2 MM (-) PBS OLIGONUCLEOTIDE; 2 REMARK 210 MM (-) PBS OLIGONUCLEOTIDE REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; OMEGA PSG REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; GE REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 1.7, NMRVIEW 3, DYANA 1.5 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 DBREF 1EN1 A 1 18 PDB 1EN1 1EN1 1 18 SEQRES 1 A 18 DG DT DC DC DC DT DG DT DT DC DG DG DG SEQRES 2 A 18 DC DG DC DC DA CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1